Inaccurate definitions of functional medicine: The authors define functional medicine as “The functional medicine model is focused on restoring optimal functioning of 3 body systems: hormonal, digestive, and detoxification.” This is an inaccurate definition and inappropriately limits an otherwise wide clinical approach; the definition of functional medicine provided by these authors is discordant with descriptions published by other groups such as the Institute for Functional Medicine and International College of Human Nutrition and Functional Medicine.
Inaccurate definitions, failure of description and citation: The sweeping statement “Restoring these 3 body systems has positive effects on stress, energy, fatigue, digestive issues, and quality of life” has no citations. Such a statement might appear intuitively reasonable for casual conversations, but in scientific publications such statements require substantiation.
Misleading statements about the use of "lifestyle" and "nutrition" when in fact steroid hormones are being administered: The authors misrepresent the intervention in the introductory text of the article by stating “The approach included lifestyle factors coupled with specific nutritional supplement protocols to treat HPA axis dysregulation and gastrointestinal infections.” To the contrary, the treatment protocol included the administration of two steroid hormones that are known to have neurotropic and antidepressant effects. Taking undefined doses of steroid hormones is neither “lifestyle factors” nor “nutritional supplementation.” Further, administration of steroid hormones requires careful patient selection and laboratory surveillance; the standard in medical practice is serum analysis—not saliva analysis via undisclosed methods. One of the hormones used in this study—DHEA—is known to convert androgens and estrogens, to estradiol and can thereby promote the development of cancers, specifically breast cancer in women. While many clinicians agree that DHEA is safe for clinical use, the implementation of DHEA administration as described in this study is at variance with clinical practice.
Failure to control for time, seasonality, and vitamin D: The authors describe the time of year of their study as “September 2014 through April 2015” but they failed to control for vitamin D levels, leaving the reader to wonder if the patients felt better to extraneous factors such as sunshine, sunlight exposure, and increased vitamin D levels—all of which are known to improve mood and cognition., Further, vitamin D also has a systemic antiinflammatory effect which would result in reduced symptomaticity. The lack of a control group, plus the change in seasons allows the conclusions to read, “The passage of time and the change of seasons toward more sunshine and warmer weather (in northern California) over six-months’ time is associated with alleviation of stress and improvement of gastrointestinal complaints regardless of treatment.”
Lack of control for social interventions: The “Lifestyle and nutritional counseling” included a 1-hour in person coaching session at the start of the study, followed by various telephone contacts and “online group sessions” including “nutrition coaching and follow-up with diet compliance.” This obviously results in the possibility that the patients felt better simply as a result of social contact and conversation with an interested educated health professional rather than as a result of any biomedical/nutritional intervention; the patients were located in the United States, a country notorious for its social isolation and lack of social networks.
Inappropriate use of meaningless lay terminology in a biomedical journal: The authors use unprofessional lay terminology “adrenal and digestive cleanse protocols” without definition, justification, or citation. In a scientific publication, these terms are meaningless without explanation.
Unreliable and undefined laboratory methods for hormonal analysis: Unreliable methods with uninterpretable results are reported, for example “A significant increase was seen in mean salivary DHEA concentration, with an initial value of 4.7 (4.8) ng/mL and an end-of-study value of 5.7 (15.4) ng/mL (P=0.047). However, the median DHEA concentration decreased from baseline to end of study (3.1-2.2 ng/mL), which suggests that the mean value may not accurately reflect the effect of the protocol on DHEA levels. In addition, 1 participant had a 36-fold increase in salivary DHEA level, which affected the mean.” Thus, the same marker was found to increase, decrease, and change inexplicably, leaving these results completely meaningless. The authors fail to detail the laboratory methodology for this saliva testing, although they do prominently mention the laboratory name.
Unreliable and undefined laboratory methods for stool testing: The results section “Stool microbial analysis” is uninterpretable with statements such as “Two participants' results for Cryptosporidium antigen changed during the study, 1 positive to negative and 1 negative to positive.” Are we to then believe that some patients acquire gastrointestinal pathogens as a result of this protocol? Again, the authors fail to detail the laboratory methodology for this microbiologic testing, although they do prominently mention the laboratory name for a second time.
Misc.: Of the 21 patients who completed the study, 2 communicated complaints or intolerance to the treatment protocol; that is nearly 10% of the study population.
Catabolic hormone profile interpreted as beneficial: Table 5 of the results shows that Cortisol/DHEA ratio started at 5.2 and resulTed at 12 at the end of the study. Consistently throughout the medical literature, respectively higher levels of cortisol and lower levels of DHEA are consistently and causatively associated with insulin resistance, hippocampal atrophy, and bone loss; to the contrary of the bulk of the peer-reviewed literature, these authors surprisingly represent these results as positive changes.
Lack of clarity regarding the product being used: The reduction in H plyori positivity from 9 to 1 subjects is expected with the use of mastic gum as listed in the protocol. According to the footnote describing this product, the authors appear unsure of the company who made the product; also, doses of active ingredients are not listed, making replication of these results in research or clinical practice impossible.
Overall lack of controls for multiple variables: The authors correctly state that “There was no control group, so positive outcomes could have been attributed to the placebo effect”; they should have expanded the range of consideration to include 2) effect of time, spontaneous resolution, 3) change in season, perhaps additional sunlight and/or higher vitamin D levels as the group transitioned from fall to spring, and 4) other population-wide economic, political, or social changes.
Failure to disclose conflicts of interest: The authors state following the conclusion that they deny conflict of interest and that “The study sponsors had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.” However, the authors completely fail to disclose who are the sponsors—the laboratories? The providers of the nutritional supplements? Speaking fees at conferences where this report will be discussed? Consulting fees? The authors prominently list many companies in the Methods and the product descriptions; presumably these are the sponsors of this article. One of the authors (Kalish) is also a consultant/employee/trainer/speaker for a large distributor of nutritional supplements, but the authors fail to describe any aspect of this relationship or even to acknowledge its existence.
This clinical trial was not registered: The authors make no mention of having registered this clinical trial with human subjects; the registering of clinical trials with human subjects is the expected standard as is widely known. Authors Cutshall, Bergstrom, and Kalish apparently did not register their human trial, and no record of the trial is available at https://clinicaltrials.gov/.